Status:

UNKNOWN

Brief Motivational Therapy Versus Usual Care for Alcohol Use Disorders in Primary Care.

Lead Sponsor:

Nicolás Barticevic

Collaborating Sponsors:

Fondo Nacional de Desarrollo Científico y Tecnológico, Chile

Conditions:

Alcohol Use Disorder

Eligibility:

All Genders

20+ years

Phase:

NA

Brief Summary

Harmful alcohol use is a leading cause of global disability and death. However increased detection and brief intervention capacity of more severe alcohol use disorders (AUD) has not been accompanied b...

Detailed Description

This exploratory trial aims to estimate the effectiveness of a BMT for AUD provided in PC. The underlying question is whether Chilean PC should incorporate this treatment among its regular programs ba...

Eligibility Criteria

Inclusion

  • Clinical diagnosis of alcohol use disorder according to the DSM-V (American Psychiatric Association, 2013
  • Must fulfill criteria for alcohol use disorder and criteria for harmful alcohol use during the last month, i.e., five or more heavy drinking occasions in the last month (5 or more drinks in men, 4 or more in women), or an average use of 14 or more drinks a week in men, and 7 or more in women
  • Also, alcohol use should be the main problem motivating participants to seek treatment.

Exclusion

  • Clients under 20 years old
  • Clients in whom alcohol use is not the main problem
  • Clients who leave the area or are unable for follow-up contact
  • Clients with severe mental comorbidity
  • Clients with severe cognitive impairment, illiteracy, or unable to follow treatment in Spanish.
  • Clients who are concurrently receiving or planning to receive other psychosocial treatment for alcohol use disorder other than usual care, i.e., formal professional treatment outside of primary care. Participation in community services and Alcoholics Anonymous is permissible.
  • Clients who have previously participated in the study, or whose family members are or have been participants.

Key Trial Info

Start Date :

November 1 2021

Trial Type :

INTERVENTIONAL

Allocation :

ESTIMATED

End Date :

November 1 2022

Estimated Enrollment :

182 Patients enrolled

Trial Details

Trial ID

NCT04345302

Start Date

November 1 2021

End Date

November 1 2022

Last Update

January 11 2022

Active Locations (3)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (3 locations)

1

CESFAM Juan Pablo II

Santiago, Chile

2

CESFAM Madre Teresa de Calcuta

Santiago, Chile

3

CESFAM San Alberto Hurtado

Santiago, Chile